For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the emergence of Tafamidis and Tafamidis meglumine represents a significant breakthrough . These groundbreaking therapies preserve the transthyretin protein, preventing its destructive build-up and lessening the impact of the condition . Individ… Read More